Pharvaris Statistics
Total Valuation
Pharvaris has a market cap or net worth of $850.92 million. The enterprise value is $498.73 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharvaris has 54.23 million shares outstanding. The number of shares has increased by 43.84% in one year.
| Current Share Class | 54.23M |
| Shares Outstanding | 54.23M |
| Shares Change (YoY) | +43.84% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 9.45% |
| Owned by Institutions (%) | 34.11% |
| Float | 19.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.59 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.08, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.08 |
| Quick Ratio | 18.81 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.77% and return on invested capital (ROIC) is -35.47%.
| Return on Equity (ROE) | -58.77% |
| Return on Assets (ROA) | -33.10% |
| Return on Invested Capital (ROIC) | -35.47% |
| Return on Capital Employed (ROCE) | -43.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.80M |
| Employee Count | 82 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharvaris has paid $1.49 million in taxes.
| Income Tax | 1.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.30% in the last 52 weeks. The beta is -3.02, so Pharvaris's price volatility has been lower than the market average.
| Beta (5Y) | -3.02 |
| 52-Week Price Change | -33.30% |
| 50-Day Moving Average | 16.69 |
| 200-Day Moving Average | 18.61 |
| Relative Strength Index (RSI) | 43.20 |
| Average Volume (20 Days) | 41,778 |
Short Selling Information
The latest short interest is 577,670, so 1.07% of the outstanding shares have been sold short.
| Short Interest | 577,670 |
| Short Previous Month | 487,308 |
| Short % of Shares Out | 1.07% |
| Short % of Float | 3.02% |
| Short Ratio (days to cover) | 11.11 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -142.51M |
| Pretax Income | -114.68M |
| Net Income | -147.46M |
| EBITDA | -142.60M |
| EBIT | -142.51M |
| Earnings Per Share (EPS) | -$2.86 |
Full Income StatementBalance Sheet
The company has $340.39 million in cash and $130,425 in debt, giving a net cash position of $340.26 million or $6.27 per share.
| Cash & Cash Equivalents | 340.39M |
| Total Debt | 130,425 |
| Net Cash | 340.26M |
| Net Cash Per Share | $6.27 |
| Equity (Book Value) | 331.01M |
| Book Value Per Share | 6.10 |
| Working Capital | 330.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$121.55 million and capital expenditures -$452,319, giving a free cash flow of -$118.17 million.
| Operating Cash Flow | -121.55M |
| Capital Expenditures | -452,319 |
| Free Cash Flow | -118.17M |
| FCF Per Share | -$2.18 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |